ASCL1 expression has been associated both with GBM cancer stem-ness22,26,27 and progenitor proliferation14 and, alternatively, with a more favourable prognosis and a propensity of GBM cells to differentiate upon inhibition of Notch signaling18. The gene discussed is ASCL1; the disease is glioblastoma.